Barely Significant
← all excerpts

TRMT1-mediated tRNA m<sup>2</sup><sub>2</sub>G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinoma.

Cell Death Dis · 2026 · PMC13408171 · PMID 42373595

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

showed a trendno p-value reported
Patients with low ATXN3 expression showed a trend toward longer PFS compared with those with high ATXN3 expression (Fig. 1F ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.